RPA is pleased to announce that both Falcon EHR and Braintree EHR have signed agreements for data interfaces with the RPA Kidney Quality Improvement Registry. These interfaces will allow physician data to populate the quality measures in the RPA Registry and will reduce provider burden. The RPA Registry may be used for MIPS reporting as well as internal quality improvement. It includes 43 quality measures, including 13 custom nephrology measures that are exclusive to the RPA Registry.
Falcon and Braintree join Allscripts, Aprima, AthenaHealth, NextGen, Quest Diagnostics/Care360, and STI Chart Maker users in providing interfaces to the RPA Registry. Allscripts, Aprima, AthenaHealth, NextGen, Quest Diagnostics/Care360, and STI Chart Maker users may access the registry through their EHRs. Acumen, Braintree, Falcon and Greenway users should contact their EHR representative for more information.
The RPA Registry is designed for nephrology practitioners to foster performance improvement and improve outcomes in the care of patients with kidney disease. As the nephrology-specific CMS-approved Qualified Clinical Data Registry (QCDR), the RPA Registry collects data for the purpose of patient and disease tracking to foster improvement in the quality of care provided to patients. The RPA Registry may be used for advancing care information (ACI) and improvement activity (IA) reporting. Learn more.